首頁 > 市場調查報告書 > 製藥

糖尿病

市場調查報告書

商品編碼

1899812

糖尿病足潰瘍治療市場規模、佔有率及成長分析（依治療方法、潰瘍類型、最終用途及地區分類）－2026-2033年產業預測

Diabetic Foot Ulcer Treatment Market Size, Share, and Growth Analysis, By Treatment (Wound Care Dressings, Biologics), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers), By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 211 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球糖尿病足潰瘍治療市場規模預計在 2024 年達到 48.9 億美元，從 2025 年的 51.5 億美元成長到 2033 年的 78.5 億美元，在預測期（2026-2033 年）內複合年成長率為 5.4%。

由於糖尿病盛行率不斷上升和人口老化，全球糖尿病足潰瘍治療市場正經歷顯著成長。隨著糖尿病患者人數的增加，對有效治療方法的需求也隨之飆升。老年人，尤其是那些患有周邊神經病變和周邊動脈疾病等慢性疾病的高風險族群，更容易發生足潰瘍。這些因素顯著推動了市場的擴張。此外，創傷護理技術的進步，例如創新敷料、生物活性材料、負壓傷口治療（NPWT）和高壓氧氣療法（HBOT），正在革新治療方法。這些技術突破不僅提高了創傷治療和閉合率，也吸引了患者和醫療服務提供者，進一步推動了市場成長。

推動全球糖尿病足潰瘍治療市場發展的因素

全球糖尿病足潰瘍治療市場的擴張主要得益於創傷護理技術的顯著進步，例如生長因子療法、生物工程皮膚替代品和創新敷料。這些進展對於改善患者預後至關重要，它們能夠加速創傷治療並最大限度地降低感染風險。例如，抗菌敷料的引入在對抗糖尿病足潰瘍常見的感染疾病發揮關鍵作用。同時，生物工程皮膚替代物透過為組織再生提供支架來加速癒合過程。這些技術的持續發展正在顯著提高全球患者照護質量，從而實現更有效、更有效率的糖尿病足潰瘍管理。

限制全球糖尿病足潰瘍治療市場的因素

全球糖尿病足潰瘍治療市場面臨的一大挑戰是許多發展中地區醫療資源和設施的匱乏。許多中低收入國家，尤其是在農村地區，醫療衛生體系落後，難以獲得糖尿病足潰瘍的專業治療。這種醫療資源的匱乏會阻礙患者及時診斷、獲得適當的創傷護理以及接受先進的治療方案。因此，這些地區的患者可能面臨健康狀況不佳、併發症風險增加以及癒合時間延長等問題，所有這些都會對整個糖尿病足潰瘍治療市場產生負面影響。

全球糖尿病足潰瘍治療市場趨勢

全球糖尿病足潰瘍治療市場目前正經歷顯著的變革時期，其主要驅動力是糖尿病盛行率的上升導致糖尿病足潰瘍病例的增加。醫療機構越來越重視先進的創傷護理技術，以改善癒合效果並減少併發症。這一趨勢包括引入創新解決方案，例如生長因子、生物工程皮膚替代物和負壓傷口治療，這些方案與傳統治療方法相比，提供了更有效、更有效率的替代方案。隨著市場的不斷發展，這些技術的整合有望改變標準的臨床實踐，並顯著改善患者照護。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

3M（United States）
Smith+Nephew（United Kingdom）
ConvaTec Group Plc（United Kingdom）
Coloplast A/S（Denmark）
Molnlycke Health Care AB（Sweden）
Integra LifeSciences Holdings Corporation（United States）
Cardinal Health, Inc.（United States）
B. Braun Melsungen AG（Germany）
Medtronic plc（Ireland）
Essity Aktiebolag（publ）（Sweden）
MIMEDX Group, Inc.（United States）
Tissue Regenix Group plc（United Kingdom）
Derma Sciences, Inc.（United States）
Medline Industries, LP（United States）
MPM Medical, Inc.（United States）
Hartmann Group（Germany）
DermaRite Industries, LLC（United States）
BioMonde（United Kingdom）
Sanara MedTech Inc.（United States）

結論與建議

簡介目錄

Product Code: SQMIG35D2236

Global Diabetic Foot Ulcer Treatment Market size was valued at USD 4.89 Billion in 2024 and is poised to grow from USD 5.15 Billion in 2025 to USD 7.85 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The global diabetic foot ulcer treatment market is witnessing significant growth driven by the rising prevalence of diabetes and an aging population. With an increasing number of individuals diagnosed with diabetes, the demand for effective treatment options is surging. The senior demographic, which is more vulnerable to chronic conditions such as peripheral neuropathy and peripheral artery disease, is particularly contributing to this market expansion as these conditions elevate foot ulcer risks. Additionally, advancements in wound care technology, including innovative dressings, bioactive materials, negative pressure wound therapy (NPWT), and hyperbaric oxygen therapy (HBOT), are revolutionizing treatment methodologies. These technological breakthroughs not only enhance wound healing and closure rates but also attract both patients and healthcare providers, thus further driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Foot Ulcer Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Foot Ulcer Treatment Market Segments Analysis

Global Diabetic Foot Ulcer Treatment Market is segmented by Treatment, Ulcer Type, End-use and region. Based on Treatment, the market is segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications and Others. Based on Ulcer Type, the market is segmented into Neuropathic Ulcers, Ischemic Ulcers and Neuro-ischemic Ulcers. Based on End-use, the market is segmented into Hospitals, Ambulatory Imaging Center and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetic Foot Ulcer Treatment Market

The expansion of the global diabetic foot ulcer treatment market is driven by significant advancements in wound care technology, such as growth factor therapies, bioengineered skin substitutes, and innovative dressings. These developments are crucial in improving patient outcomes by accelerating wound healing and minimizing infection risks. For instance, the introduction of antimicrobial dressings plays a vital role in combating infections frequently associated with diabetic foot ulcers, while bioengineered skin substitutes facilitate the healing process by providing a scaffold for tissue regeneration. The continuous evolution of these technologies greatly enhances the quality of patient care worldwide, leading to more effective and efficient management of diabetic foot ulcers.

Restraints in the Global Diabetic Foot Ulcer Treatment Market

A significant challenge facing the global diabetic foot ulcer treatment market is the limited availability of healthcare resources and facilities in many developing regions. In numerous low- and middle-income countries, particularly in rural areas, healthcare systems are underdeveloped, leading to restricted access to specialized care for diabetic foot ulcers. This lack of accessibility can hinder timely diagnosis, proper wound care, and advanced treatment options for patients. Consequently, individuals in these regions may experience poorer health outcomes, an increased risk of complications, and prolonged healing times, all of which can adversely affect the overall market for diabetic foot ulcer treatment.

Market Trends of the Global Diabetic Foot Ulcer Treatment Market

The Global Diabetic Foot Ulcer Treatment market is currently witnessing a significant shift driven by the escalating prevalence of diabetes, leading to a corresponding rise in diabetic foot ulcers. Healthcare providers are increasingly focusing on advanced wound care technologies aimed at enhancing healing outcomes and reducing complications. This trend includes the adoption of innovative solutions such as growth factors, bioengineered skin substitutes, and negative pressure wound therapy, which provide more effective and efficient alternatives compared to traditional treatment methods. As the market evolves, the integration of these technologies is expected to transform standard practices and improve patient care significantly.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Diabetic Foot Ulcer Treatment Market Size by Treatment & CAGR (2026-2033)

Market Overview
Wound Care Dressings
- Alginate Dressings
- Hydrofiber Dressings
- Foam Dressings
- Film Dressing
- Hydrocolloid Dressings
- Surgical Dressings
- Hydrogel Dressings
Biologics
- Growth Factors
- Skin Grafts
Therapy Devices
- Negative Pressure Wound Therapy
- Ultrasound Therapy
Antibiotic Medications
Others

Global Diabetic Foot Ulcer Treatment Market Size by Ulcer Type & CAGR (2026-2033)

Market Overview
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers

Global Diabetic Foot Ulcer Treatment Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Imaging Center
Homecare

Global Diabetic Foot Ulcer Treatment Market Size & CAGR (2026-2033)

North America (Treatment, Ulcer Type, End-use)
- US
- Canada
Europe (Treatment, Ulcer Type, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment, Ulcer Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment, Ulcer Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment, Ulcer Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

3M (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConvaTec Group Plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag (publ) (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MIMEDX Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Regenix Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, LP (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPM Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hartmann Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DermaRite Industries, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMonde (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanara MedTech Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments